Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             123 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens Jerlhag, Elisabet
 2008
 18 Supplement 2 p. 508-518
11 p.
 artikel
2 Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks Micale, Vincenzo
 2008
 18 Supplement 2 p. 462-471
10 p.
 artikel
3 Cannabinoid and opioid modulation of social play behavior in adolescent rats: Differential behavioral mechanisms Trezza, Viviana
 2008
 18 Supplement 2 p. 519-530
12 p.
 artikel
4 C.12.02 Current long term treatments for bipolar disorder Yatham, L.
 2008
 18 Supplement 2 p. S601-
1 p.
 artikel
5 C.21.03 Improving ratings quality in CNS clinical trials Targum, S.
 2008
 18 Supplement 2 p. S612-
1 p.
 artikel
6 C.08.02 Improving the pharmacokinetic profile of antipsychotics – what difference does it make? Pani, L.
 2008
 18 Supplement 2 p. S596-
1 p.
 artikel
7 C.17.03 Increasing compliance with anti-depressant treatment Burrows, G.
 2008
 18 Supplement 2 p. S607-
1 p.
 artikel
8 C.22.03 Long-term treatment of bipolar disorder: making sense of RCTs and observational studies Young, T.
 2008
 18 Supplement 2 p. S613-
1 p.
 artikel
9 Contents 2008
 18 Supplement 2 p. OBC-
1 p.
 artikel
10 Contents 2008
 18 Supplement 2 p. iii-
1 p.
 artikel
11 Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after recovery from an acute episode of moderate depression — A double-blind, randomized, placebo controlled long-term trial Kasper, S.
 2008
 18 Supplement 2 p. 803-813
11 p.
 artikel
12 C.03.01 Predictors of onset and outcome in psychosis Murray, R.
 2008
 18 Supplement 2 p. S590-
1 p.
 artikel
13 C.07.02 Recent advances in the short-term management of bipolar disorder Calabrese, J.
 2008
 18 Supplement 2 p. S594-S595
2 p.
 artikel
14 Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial Davidson, Jonathan R.T.
 2008
 18 Supplement 2 p. 673-681
9 p.
 artikel
15 Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects Ellgren, M.
 2008
 18 Supplement 2 p. 826-834
9 p.
 artikel
16 ECNP announcement - Breaking News 2008
 18 Supplement 2 p. II-
1 p.
 artikel
17 ECNP announcement - Call for applications - Editor-in-Chief 2008
 18 Supplement 2 p. I-II
nvt p.
 artikel
18 ECNP 2009 Award for outstanding scientists 2008
 18 Supplement 2 p. II-
1 p.
 artikel
19 Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies Stein, Dan J.
 2008
 18 Supplement 2 p. 422-430
9 p.
 artikel
20 Factors triggering abolishment of benzodiazepines effects in the four-plate test–retest in mice Petit-Demoulière, B.
 2008
 18 Supplement 2 p. 41-47
7 p.
 artikel
21 Global DNA methylation is influenced by smoking behaviour Hillemacher, Thomas
 2008
 18 Supplement 2 p. 295-298
4 p.
 artikel
22 Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway Peng, Chi-Hsien
 2008
 18 Supplement 2 p. 128-140
13 p.
 artikel
23 Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test Ghasemi, Mehdi
 2008
 18 Supplement 2 p. 323-332
10 p.
 artikel
24 α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access Wee, Sunmee
 2008
 18 Supplement 2 p. 303-311
9 p.
 artikel
25 Norchloro-fluoro-homoepibatidine (NCFHEB) — A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET Deuther-Conrad, W.
 2008
 18 Supplement 2 p. 222-229
8 p.
 artikel
26 P.2.a.012 A diagnosis of depression is associated with increased hypnotic use in primary care Donoghue, J.
 2008
 18 Supplement 2 p. S299-
1 p.
 artikel
27 P.1.a.001 Apolipoprotein E and cyclooxygenase 2 −765 G>C polymorphisms in Alzheimer's dementia Juhasz, A.
 2008
 18 Supplement 2 p. S203-
1 p.
 artikel
28 P.2.a.027 Association between tryptophan hydroxylase 2 gene and the personality traits of novelty seeking and harm avoidance Nam, Y.Y.
 2008
 18 Supplement 2 p. S307-S308
2 p.
 artikel
29 P.1.a.020 Association study of polymorphisms in GABA and glycine transporter gene with schizophrenia in the Korean population Kim, J.W.
 2008
 18 Supplement 2 p. S214-
1 p.
 artikel
30 P.2.10 Aberrant cytokine response to stress in BALB/c mice after lipopolysaccharide (LPS) challenge: relevance of tryptophan hydroxylase 2 Browne, C.A.
 2008
 18 Supplement 2 p. s44-s45
nvt p.
 artikel
31 P.8.a.017 Controlled study of gonadal axis hormones in male suicide attempters Perez-Rodriguez, M.M.
 2008
 18 Supplement 2 p. S576-S577
2 p.
 artikel
32 P.6.a.010 Differential effects of stress on alcohol-related behaviours in moderate and heavy social drinkers Nesic, J.
 2008
 18 Supplement 2 p. S524-S525
2 p.
 artikel
33 P.2.a.023 Effect of polymorphisms in the tryptophan hydroxylase 2 gene on suicide risk in Korean with major depressive disorder Nam, Y.Y.
 2008
 18 Supplement 2 p. S305-
1 p.
 artikel
34 P.2.a.026 Effects of metoclopramide on 5-HTP induced activation of the hypothalamus-pituitary-adrenal (HPA) axis Jacobs, G.
 2008
 18 Supplement 2 p. S307-
1 p.
 artikel
35 P.7.a.005 Long-term efficacy and safety of aripiprazole in children and adolescents with mania Forbes, A.
 2008
 18 Supplement 2 p. S556-S557
2 p.
 artikel
36 P.8.a.014 Milnacipran for the treatment of fibromyalgia syndrome: a european multicenter, double-blind, placebo-controlled trial Branco, J.
 2008
 18 Supplement 2 p. S574-S575
2 p.
 artikel
37 P.1.a.003 Neonatal behavioral characteristics and gene polymorphisms of serotonin 2a, 2c, 6 receptors and serotonin transporter Kim, H.C.
 2008
 18 Supplement 2 p. S204-
1 p.
 artikel
38 P.4.a.013 Patients with “pure OCD” incur higher 2-year psychotropic costs than patients with “pure depression” Hankin, C.
 2008
 18 Supplement 2 p. S485-
1 p.
 artikel
39 P.2.a.009 Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder Kasper, S.
 2008
 18 Supplement 2 p. S297-S298
2 p.
 artikel
40 P.4.a.002 Psychopharmacotherapy and suicidal behaviour of patients with anxiety and stress related disorders Segrec, N.
 2008
 18 Supplement 2 p. S478-S479
2 p.
 artikel
41 P.5.a.003 Risperidone vs. haloperidol in treatment of delirium superimposed on dementia Djokic, G.
 2008
 18 Supplement 2 p. S504-S505
2 p.
 artikel
42 P.5.a.006 Safety comparison of once-daily versus twice-daily memantine for the treatment of Alzheimer's patients: a pooled analysis Jones, R.
 2008
 18 Supplement 2 p. S506-
1 p.
 artikel
43 P.1.a.006 Serotonin transporter: an example of gene influence on human behaviour Calati, R.
 2008
 18 Supplement 2 p. S205-S206
2 p.
 artikel
44 P.8.a.031 Sleep stages and automatic overnight cortisol sampling Wilson, S.
 2008
 18 Supplement 2 p. S584-S585
2 p.
 artikel
45 P.3.a.013 The effect of depression and anxiety symptoms on the results of combined dexamethasone/corticotrophine releasing hormone test in schizophrenia Lee, S.I.
 2008
 18 Supplement 2 p. S392-S393
2 p.
 artikel
46 P.2.a.002 Treatment milestones predict symptom remission over 6-month treatment of patients with major depressive disorder (MDD) Wade, A.
 2008
 18 Supplement 2 p. S293-S294
2 p.
 artikel
47 P.2.a.007 Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression Kloiber, S.
 2008
 18 Supplement 2 p. S296-
1 p.
 artikel
48 P.6.a.007 Venlafaxine vs. alprazolam in the treatment of alcohol dependence Lazarova, V.
 2008
 18 Supplement 2 p. S522-S523
2 p.
 artikel
49 P.7.a.008 Why and how do adolescents self injure Mitic, M.
 2008
 18 Supplement 2 p. S558-S559
2 p.
 artikel
50 P.2.b.014 Chronic stress in rats as model for depression: effects of citalopram on expression of TPH isoforms 1 and 2 Abumaria, N.
 2008
 18 Supplement 2 p. S320-S321
2 p.
 artikel
51 P.4.b.003 Effect of a tryptophan hydroxylase 2 gene polymorphism on panic disorder Yoon, H.K.
 2008
 18 Supplement 2 p. S488-
1 p.
 artikel
52 P.6.b.007 Effects of glutamine, N-acetylcysteine, lipoic acid and succinate on alcohol withdrawal signs in rats Pronko, P.S.
 2008
 18 Supplement 2 p. S530-S531
2 p.
 artikel
53 P.2.b.021 Gender differences in serotonin transporter availability in patients with major depression Uebelhack, K.
 2008
 18 Supplement 2 p. S324-
1 p.
 artikel
54 P.3.b.010 Markers of oxidative stress in patients with schizophrenia and metabolic syndrome. Preliminary study Nemes, B.
 2008
 18 Supplement 2 p. S403-
1 p.
 artikel
55 P.4.b.001 Role of transient receptor potential vanilloid type 1 channels in brain regions related to anxiety in rats Bertoglio, L.J.
 2008
 18 Supplement 2 p. S487-
1 p.
 artikel
56 P.4.b.004 The change of heart rate variability during 6-week pharmacotherapy in patients with panic disorder Kim, W.
 2008
 18 Supplement 2 p. S488-S489
2 p.
 artikel
57 P.2.b.004 The chronic variable stress sensitizes the startle reflex to footshock Kanai, S.
 2008
 18 Supplement 2 p. S315-
1 p.
 artikel
58 P.2.b.007 The effect of sub-convulsive electrical stimulation and electroconvulsive therapy (ECT) in a rat model for depression Toth, E.
 2008
 18 Supplement 2 p. S316-S317
2 p.
 artikel
59 P.1.c.004 Acute paroxetine or alprazolam attenuate defensive responses of hamsters confronted with venomous coral snake Paschoalin-Maurin, T.
 2008
 18 Supplement 2 p. S222-S223
2 p.
 artikel
60 P.1.c.021 Amitriptyline does not potentiate the anti-hyperalgesic effects of gabapentin in a model of painful diabetic neuropathy Petrovic, R. Stepanovic
 2008
 18 Supplement 2 p. S232-
1 p.
 artikel
61 P.3.c.022 Analyses of genetic factors in olanzapine-induced weight gain in schizophrenic patients Ujike, H.
 2008
 18 Supplement 2 p. S417-
1 p.
 artikel
62 P.2.c.031 A national patient sleep assessment questionnaire in depression (NAPSAQ II); a survey for general practitioners Paterson, L.M.
 2008
 18 Supplement 2 p. S342-
1 p.
 artikel
63 P.1.c.001 An ethopharmacological assessment of the effects of (R, S)-2-chloro-5-hydroxyphenylglycine (CHPG) on agonistic interactions in male mice Huertas, P.
 2008
 18 Supplement 2 p. S220-S221
2 p.
 artikel
64 P.3.c.057 An evaluation of the clinical value of aripiprazole in the treatment of mania Donoghue, J.M.
 2008
 18 Supplement 2 p. S436-S437
2 p.
 artikel
65 P.2.c.017 Do tramadol and dopamine-blocking agents enhance the risk of mirtazapine-associated restless legs syndrome? Kim, S.W.
 2008
 18 Supplement 2 p. S334-
1 p.
 artikel
66 P.3.c.071 Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: The METEOR Study De Hert, M.
 2008
 18 Supplement 2 p. S444-S445
2 p.
 artikel
67 P.2.c.035 Health care utilization and costs of depressed patients treated with escitalopram versus SNRIs Erder, M.H.
 2008
 18 Supplement 2 p. S343-S344
2 p.
 artikel
68 P.6.c.012 Implicit and explicit drug-related cognitions in an ecological momentary assessment setting Marhe, R.
 2008
 18 Supplement 2 p. S538-S539
2 p.
 artikel
69 P.3.c.012 Metabolic syndrome among patients with psychotic disorders treated with clozapine van der Heijden, F.M.M.A.
 2008
 18 Supplement 2 p. S411-
1 p.
 artikel
70 P.1.c.045 Modulation of hippocampal gamma (30–80 Hz) frequency oscillations in vitro by serotonin Eden, D.C.
 2008
 18 Supplement 2 p. S245-
1 p.
 artikel
71 P.1.c.048 Nitric oxide modulate methylphenidate-induced disruption on prepulse inhibition of the acoustic startle in swiss mice Issy, A.C.
 2008
 18 Supplement 2 p. S247-
1 p.
 artikel
72 P.3.c.054 Olanzapine long-acting injection in patients with schizophrenia at risk of relapse: 12-week switching data Detke, H.
 2008
 18 Supplement 2 p. S435-
1 p.
 artikel
73 P.3.c.040 Risk of metabolic, cardiologic, and endocrinologic abnormalities in patients under long-term antipsychotic treatment Cerveri, G.
 2008
 18 Supplement 2 p. S426-S427
2 p.
 artikel
74 P.3.c.013 Risperidone long acting injection: 2 year outcomes in a naturalistic study Deslandes, P.
 2008
 18 Supplement 2 p. S411-S412
2 p.
 artikel
75 P.1.c.007 Serotonin pathway genes polymorphisms and the clinical response to citalopram among children and adolescents Rotberg, B.
 2008
 18 Supplement 2 p. S224-
1 p.
 artikel
76 P.3.c.026 The questionnaire of the usage of depot injection in Japan Kanazawa, T.
 2008
 18 Supplement 2 p. S418-S419
2 p.
 artikel
77 P.1.c.035 The role of nitric oxide in PC12 cells death. Protective effect of 12-lipoxygenase and cyclooxygenases inhibitors Pytlowany, M.
 2008
 18 Supplement 2 p. S239-S240
2 p.
 artikel
78 P.3.05 Current and former ecstasy users report different sleep to matched controls: a web based questionnaire study Carhart-Harris, R.
 2008
 18 Supplement 2 p. s66-s67
nvt p.
 artikel
79 P.4.d.004 Anxiolytic-like effects induced by noradrenaline microinjected into the dorsal periaqueductal gray of rats Pelosi, G.G.
 2008
 18 Supplement 2 p. S496-S497
2 p.
 artikel
80 P.3.d.008 Asenapine pharmacokinetics: influence of cytochrome p450 modulators and udp-glucuronyltransferase inhibition Dogterom, P.
 2008
 18 Supplement 2 p. S452-S453
2 p.
 artikel
81 P.6.d.016 Distinct time-course of behavioral sensitization induced by ethanol or cocaine Oliveira-Lima, A.J.
 2008
 18 Supplement 2 p. S548-
1 p.
 artikel
82 P.2.d.022 Do antidepressant drugs affect aversive memory functions in the forced swim test? Wardi, T.
 2008
 18 Supplement 2 p. S357-
1 p.
 artikel
83 P.2.d.012 Further characterization of norquetiapine and quetiapine in rodent models of antidepressant and anxiolytic action Hudzik, T.
 2008
 18 Supplement 2 p. S351-S352
2 p.
 artikel
84 P.3.d.011 Immunotropic effects of atypical neuroleptics olanzapine and amisulpride Lobacheva, O.A.
 2008
 18 Supplement 2 p. S454-S455
2 p.
 artikel
85 P.1.d.011 Phosphonate analogue of ketoglutarate increases activity of ketoglutarate dehydrogenasecomplex in situ and in vivo Trofimova, L.K.
 2008
 18 Supplement 2 p. S254-S255
2 p.
 artikel
86 P.5.d.002 Stereospecific synthesis and potential neuroprotective activity of alkaloid securinine derivatives Klochkov, S.
 2008
 18 Supplement 2 p. S514-S515
2 p.
 artikel
87 P.2.e.014 Are antiepileptic mood stabilizers really effective in psychotic bipolar mania? Marinkovic, D.
 2008
 18 Supplement 2 p. S366-S367
2 p.
 artikel
88 P.2.18 Effects of serotonin1B (5-HT1B) receptor ligands in cocaine priming, discrete cue or food-induced relapses in rats Golda, A.
 2008
 18 Supplement 2 p. s51-s52
nvt p.
 artikel
89 P.7.e.001 Interferon gamma and interleukin 6 in children with obsessive-compulsive and spectrum disorders Komorowska-Pietrzykowska, R.
 2008
 18 Supplement 2 p. S566-S567
2 p.
 artikel
90 P.3.e.002 Prognostic value of affective symptomatology in first-admitted psychotic patients: a three-year follow-up study Arrasate, M.
 2008
 18 Supplement 2 p. S462-S463
2 p.
 artikel
91 P.1.e.010 The investigation of orbitofrontal cortex and amygdala association in depressed patients by structural equation modeling Zengin, B.
 2008
 18 Supplement 2 p. S264-S265
2 p.
 artikel
92 P.2.e.011 The role of psychotic features in bipolar disorder Ozyildirim, I.
 2008
 18 Supplement 2 p. S365-
1 p.
 artikel
93 P.2.21 Exposure to an open-field induces c-Fos in a distributed anxiety-related system projecting to the basolateral amygdala Hale, M.
 2008
 18 Supplement 2 p. s53-s54
nvt p.
 artikel
94 P.1.g.001 Are impairments of sleep-dependent memory consolidation in depression related to HPA axis dysfunction? Dresler, M.
 2008
 18 Supplement 2 p. S273-
1 p.
 artikel
95 P.1.g.018 Cognitive performance in adolescents with anorexia nervosa: subgroups in relation to neuropsychological impairment Perpiña, S. Andres
 2008
 18 Supplement 2 p. S283-S284
2 p.
 artikel
96 P.1.g.004 Neurocognitive deficit changes in relation to the course of schizophrenia: five-year follow-up study Zaytseva, Y.
 2008
 18 Supplement 2 p. S275-
1 p.
 artikel
97 P.2.g.003 Type D personality and depression in Portuguese patients with acute coronary syndrome: identifying high risk groups Prata, J.
 2008
 18 Supplement 2 p. S374-S375
2 p.
 artikel
98 P.2.h.001 Both R(−)- and S(+)-citalopram attenuates neuronal apoptosis in murine cortical cell culture Noh, J.S.
 2008
 18 Supplement 2 p. S382-S383
2 p.
 artikel
99 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine Hashimoto, Kenji
 2008
 18 Supplement 2 p. 414-421
8 p.
 artikel
100 Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice Hebb, Andrea L.O.
 2008
 18 Supplement 2 p. 339-363
25 p.
 artikel
101 P.2.h.003 The behavioral and cardiovascular effects of a novel partial alpha-2 adrenoceptor agonist naphthylmedetomidine Votava, M.
 2008
 18 Supplement 2 p. S383-S384
2 p.
 artikel
102 P.2.h.002 The effect of different alpha-2 adrenoceptor ligands on aggression in mice Votava, M.
 2008
 18 Supplement 2 p. S383-
1 p.
 artikel
103 P.2.h.004 The tryptophan hydroxylase a218c polymorphism in the korean patients with depressive disorder Jeong, H.
 2008
 18 Supplement 2 p. S384-
1 p.
 artikel
104 P.1.i.007 Differential brain, but not serum vascular endothelial growth factor levels in a genetic rat model of depression Elfving, B.
 2008
 18 Supplement 2 p. S291-S292
2 p.
 artikel
105 P.1.30 Inflammation down-regulates β2-adrenoceptor expression on primary glia: reversal by the glucocorticoid dexamethasone Ryan, K.M.
 2008
 18 Supplement 2 p. s25-s26
nvt p.
 artikel
106 P.4.07 Peroxisome proliferator-activated receptors (PPARs): new target for attention and memory function Mazzola, C.
 2008
 18 Supplement 2 p. s90-s91
nvt p.
 artikel
107 P.1.13 Pulsatile glucocorticoid secretion: does it matter? Wiles, C.C.
 2008
 18 Supplement 2 p. s12-
1 p.
 artikel
108 P.3.22 Serotonin1A receptor distribution may predict neural reactivity as shown by multimodal neuroimaging with fMRI and PET Fink, M.
 2008
 18 Supplement 2 p. s80-s81
nvt p.
 artikel
109 P.1.27 The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor and FK506 binding protein 51 (FKBP-51) concentration in animal model of depression Otczyk, M.
 2008
 18 Supplement 2 p. s23-s24
nvt p.
 artikel
110 P.2.04 The effect of two behavioral tests on the corticosterone level in plasma of mice lacking the noradrenaline transporter Solich, J.
 2008
 18 Supplement 2 p. s40-
1 p.
 artikel
111 S.04.07 Could nicotine potentiate the beneficial effects of levodopa in the 6-OHDA rat model? A behavioural study Guilloux, J.P.
 2008
 18 Supplement 2 p. S162-S163
2 p.
 artikel
112 S.17.03 Genetic effects on stress sensitivity den Boer, J.A.
 2008
 18 Supplement 2 p. S180-
1 p.
 artikel
113 S.24.01 Neurosteroids: endogenous modulators of GABA-A receptor Lambert, J.
 2008
 18 Supplement 2 p. S190-S191
2 p.
 artikel
114 S.28.04 Pharmacogenetics of mood stabiliser in bipolar disorder de Leon, J.
 2008
 18 Supplement 2 p. S197-
1 p.
 artikel
115 S.02.03 Predictive models of suicidal behaviour in mood disorders Mann, J.
 2008
 18 Supplement 2 p. S157-
1 p.
 artikel
116 S.07.04 Progesterone and estradiol plasma levels modulate serotonin-1A binding in the human brain Spindelegger, C.
 2008
 18 Supplement 2 p. S168-
1 p.
 artikel
117 S.07.07 Seven days of citalopram reduces sensitivity to negative appraisal in a probabilistic learning task Browning, M.
 2008
 18 Supplement 2 p. S169-S170
2 p.
 artikel
118 S.18.01 The adolescent depression antidepressant and psychotherapy trial (ADAPT) Dubicka, B.
 2008
 18 Supplement 2 p. S181-
1 p.
 artikel
119 S.21.05 The role of NMDAR neurotransmission modulators in the early treatment of schizophrenia Heresco-Levy, U.
 2008
 18 Supplement 2 p. S186-S187
2 p.
 artikel
120 S.11.04 The use of inbred strains for the development of animal models of anxiety Landgraf, R.
 2008
 18 Supplement 2 p. S174-S175
2 p.
 artikel
121 S.01.05 What are the advantages of new formulations of antipsychotic drugs? Pani, L.
 2008
 18 Supplement 2 p. S156-
1 p.
 artikel
122 Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain Oliva, José M.
 2008
 18 Supplement 2 p. 373-382
10 p.
 artikel
123 Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder Hernández, María Eugenia
 2008
 18 Supplement 2 p. 917-924
8 p.
 artikel
                             123 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland